Lupus registry for patients and caregivers
Part of Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study creates a registry for people with lupus and their families. It helps researchers learn more about lupus and improve care. You or your child can join if you have a lupus diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older, or you are a parent or legal guardian of a child under 18 with lupus.
- You have a diagnosis of lupus from a doctor or health care provider, or you are a legal guardian of someone who does.
- You can read and understand English well enough to complete online surveys.
- You have access to a computer or device with internet.
- You are willing to provide consent (or give permission for a child or adult who can't consent).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study keeps a long-term record of people with lupus (systemic lupus erythematosus) and collects samples so researchers can study the disease better. You may be able to join if you meet lupus diagnosis criteria, are not pregnant, and can follow the study visits and consent process.
This trial collects health data from people recently diagnosed with lupus to improve treatment and care. It is a registry study, not a drug-testing trial, and aims to understand how patients fare over time.
This study tests a care program for people with lupus-related kidney disease. It uses telemedicine visits to help manage your condition and improve your care.
This trial tests a new kind of treatment called CRC01, which uses your own immune cells modified to attack and calm the overactive immune system that causes lupus. It's for people with severe lupus that affects the kidneys and hasn't improved with standard therapies, and it aims to reduce disease activity and prevent further damage.
This research study aims to better understand systemic lupus erythematosus (SLE), an autoimmune disease where the body's immune system attacks its own tissues. Researchers will evaluate patients with lupus, study genetic factors, and perform optional imaging tests to learn how the disease affects blood vessels and the heart.
This is a registry study for people living with systemic lupus erythematosus (lupus). By joining, you help researchers collect information about lupus to better understand the disease and improve care.
Hear when a new Cutaneous Lupus Erythematosus (CLE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.